miR-122 Release in Exosomes Precedes Overt Tolvaptan-Induced Necrosis in a Primary Human Hepatocyte Micropatterned Coculture Model
出版年份 2017 全文链接
标题
miR-122 Release in Exosomes Precedes Overt Tolvaptan-Induced Necrosis in a Primary Human Hepatocyte Micropatterned Coculture Model
作者
关键词
-
出版物
TOXICOLOGICAL SCIENCES
Volume 161, Issue 1, Pages 149-158
出版商
Oxford University Press (OUP)
发表日期
2017-09-28
DOI
10.1093/toxsci/kfx206
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Exploring Chronic Drug Effects on Microengineered Human Liver Cultures Using Global Gene Expression Profiling
- (2017) Brenton R. Ware et al. TOXICOLOGICAL SCIENCES
- microRNA-17 family promotes polycystic kidney disease progression through modulation of mitochondrial metabolism
- (2017) Sachin Hajarnis et al. Nature Communications
- How Reactive Metabolites Induce an Immune Response That Sometimes Leads to an Idiosyncratic Drug Reaction
- (2016) Tiffany Cho et al. CHEMICAL RESEARCH IN TOXICOLOGY
- APSN young investigator award - Basic science
- (2016) NEPHROLOGY
- Subtoxic Alterations in Hepatocyte-Derived Exosomes: An Early Step in Drug-Induced Liver Injury?
- (2016) Natalie S. Holman et al. TOXICOLOGICAL SCIENCES
- Application of a Mechanistic Model to Evaluate Putative Mechanisms of Tolvaptan Drug-Induced Liver Injury and Identify Patient Susceptibility Factors
- (2016) Jeffrey L. Woodhead et al. TOXICOLOGICAL SCIENCES
- Characterization of primary human hepatocyte spheroids as a model system for drug-induced liver injury, liver function and disease
- (2016) Catherine C. Bell et al. Scientific Reports
- Mechanisms of tolvaptan-induced toxicity in HepG2 cells
- (2015) Yuanfeng Wu et al. BIOCHEMICAL PHARMACOLOGY
- Clinical Pattern of Tolvaptan-Associated Liver Injury in Subjects with Autosomal Dominant Polycystic Kidney Disease: Analysis of Clinical Trials Database
- (2015) Paul B. Watkins et al. DRUG SAFETY
- Ursodeoxycholic acid inhibits hepatic cystogenesis in experimental models of polycystic liver disease
- (2015) Patricia Munoz-Garrido et al. JOURNAL OF HEPATOLOGY
- Hormone and Drug-Mediated Modulation of Glucose Metabolism in a Microscale Model of the Human Liver
- (2015) Matthew D. Davidson et al. TISSUE ENGINEERING PART C-METHODS
- Prediction of Drug-Induced Liver Injury in Micropatterned Co-cultures Containing iPSC-Derived Human Hepatocytes
- (2015) Brenton R. Ware et al. TOXICOLOGICAL SCIENCES
- Exosomes derived from alcohol-treated hepatocytes horizontally transfer liver specific miRNA-122 and sensitize monocytes to LPS
- (2015) Fatemeh Momen-Heravi et al. Scientific Reports
- A Micropatterned Hepatocyte Coculture Model for Assessment of Liver Toxicity Using High-Content Imaging Analysis
- (2014) O. Joseph Trask et al. ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES
- Genetic Basis of Drug-Induced Liver Injury: Present and Future
- (2014) Thomas Urban et al. SEMINARS IN LIVER DISEASE
- Role of Nrf2 in Oxidative Stress and Toxicity
- (2013) Qiang Ma Annual Review of Pharmacology and Toxicology
- Short-term renal hemodynamic effects of tolvaptan in subjects with autosomal dominant polycystic kidney disease at various stages of chronic kidney disease
- (2013) Wendy E. Boertien et al. KIDNEY INTERNATIONAL
- Importance of RNA isolation methods for analysis of exosomal RNA: Evaluation of different methods
- (2012) Maria Eldh et al. MOLECULAR IMMUNOLOGY
- Tolvaptan in Patients with Autosomal Dominant Polycystic Kidney Disease
- (2012) Vicente E. Torres et al. NEW ENGLAND JOURNAL OF MEDICINE
- Use of Micropatterned Cocultures to Detect Compounds That Cause Drug-Induced Liver Injury in Humans
- (2012) Salman R. Khetani et al. TOXICOLOGICAL SCIENCES
- A Mouse Diversity Panel Approach Reveals the Potential for Clinical Kidney Injury Due to DB289 Not Predicted by Classical Rodent Models
- (2012) Alison H. Harrill et al. TOXICOLOGICAL SCIENCES
- Effects of CYP3A4 inhibition and induction on the pharmacokinetics and pharmacodynamics of tolvaptan, a non-peptide AVP antagonist in healthy subjects
- (2011) Susan E. Shoaf et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Nonclinical Pharmacokinetics of a New Nonpeptide V2 Receptor Antagonist, Tolvaptan
- (2011) Masayuki Furukawa et al. CARDIOVASCULAR DRUGS AND THERAPY
- HLA-DQA1*02:01 Is a Major Risk Factor for Lapatinib-Induced Hepatotoxicity in Women With Advanced Breast Cancer
- (2011) Colin F. Spraggs et al. JOURNAL OF CLINICAL ONCOLOGY
- Quantitative analyses and transcriptomic profiling of circulating messenger RNAs as biomarkers of rat liver injury
- (2010) Barbara A. Wetmore et al. HEPATOLOGY
- Analysis of circulating microRNA biomarkers in plasma and serum using quantitative reverse transcription-PCR (qRT-PCR)
- (2010) Evan M. Kroh et al. METHODS
- A genome-wide study identifies HLA alleles associated with lumiracoxib-related liver injury
- (2010) Jonathan B Singer et al. NATURE GENETICS
- Cellular Imaging Predictions of Clinical Drug-Induced Liver Injury
- (2008) Jinghai J. Xu et al. TOXICOLOGICAL SCIENCES
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started